Kainic acid seizures depleted hippocampal enkephalin by 31% and dynorphin by 63%, then both rebounded 2-3 fold above normal within 48 hours.
63% dynorphin depletionDuring seizures, followed by 170% rebound at 48 hours
What the researchers found
A single injection of kainic acid (1 microgram) into rat brains caused seizures lasting 3 to 6 hours. During seizures, hippocampal met-enkephalin dropped 31% and dynorphin A dropped 63%, suggesting these opioid peptides were being released.
By 24 hours, levels returned to normal. By 48 hours, met-enkephalin surged to 270% of normal and dynorphin to 150%. The brain had ramped up production to replace what was used.
The biosynthetic machinery confirmed this: mRNA for preproenkephalin (the genetic template for making enkephalin) jumped to 400% of control at 6 hours. The actual precursor protein followed at 24 hours, reaching 300% of control.
The seizure-induced shaking behavior (wet-dog shakes) was directly linked to enkephalin. Naloxone (an opioid blocker) reduced the shaking. Anti-enkephalin antibodies also reduced it. Injecting enkephalin peptides into the hippocampus mimicked the shaking.
Why it matters
This study mapped the complete cycle of opioid peptide release and replenishment in the brain during seizures. It showed the brain has a powerful compensatory mechanism to restore its opioid supply. Understanding this process matters for epilepsy research and for understanding how the brain's natural painkillers respond to injury.
How the study worked
Rats received a single intracerebral injection of kainic acid (1 microgram). Opioid peptide levels were measured by immunoassay at multiple time points (6, 24, 48 hours). Immunocytochemistry visualized peptide location. mRNA levels were measured to track biosynthesis. Pharmacological experiments (naloxone, antibodies, direct peptide injection) tested the functional role of enkephalin in seizure behavior.
What this study cannot tell us
Tested in rats, not people. The kainic acid seizure model is artificial and does not perfectly mimic human epilepsy. The study focused on the hippocampus; other brain regions may respond differently. Only one dose of kainic acid was tested.
How to read the evidence
Preliminary animal study showing clear effects but in a chemical seizure model, not naturally occurring epilepsy.
When this study was published
Published in 1987 — foundational work on seizure-opioid peptide interactions.
The bigger picture
Understanding how seizures alter brain opioid peptides could lead to new epilepsy treatments. The dramatic rebound overproduction suggests the brain has built-in protective mechanisms that could be therapeutically harnessed.
Questions still open
- Does the opioid rebound protect against future seizures?
- Could targeting the opioid system prevent epilepsy progression?
Common questions
What are endogenous opioid peptides?
Why did opioid levels rebound above normal?
Read the original research
Kainic acid as a tool to study the regulation and function of opioid peptides in the hippocampus.
Toxicology, 46(2), 141-57
Citation
Hong, J S; Grimes, L; Kanamatsu, T; McGinty, J F. (1987). Kainic acid as a tool to study the regulation and function of opioid peptides in the hippocampus.. Toxicology, 46(2), 141-57.